|
Shingles
References
Acosta E, Balfour H. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Journal of Antimicrobial Agents and Chemotherapy. 2001;45: 2771-2774.
Fitzpatrick T. Varicella and Herpes Zoster. Dermatology in General Medicine. 5th ed. vol 2. New York: McGraw Hill; 1999: 2427-2450.
Gorbach S, Bartlett J. Varicella Zoster Virus. In: Infectious Diseases. 2nd ed. Philadelphia: W.B. Sanders; 1998. pages 1311-1323, 2081-2084.
Herpes Zoster. American Academy of Dermatology website. Available at: http://www.aad.org/pamphlets/herpesZoster.html. Accessed December 2007.
Oxman MN, Levin MJ, et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. N Engl J Med. 2005; 352: 2271-2284.
Raja S, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59(7):1015-1021.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. Journal of the American Medical Association. 1998;280(21):1837-1842.
Zostavax prescribing information. Merck & Co., Inc. Whitehouse Station, NJ. July 2007.
|
References
